Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Virchows Archiv
Published in: Virchows Archiv 4/2007

01-10-2007 | Original Article

Association of progressive structural changes in the bronchial epithelium with subepithelial fibrous remodeling: A potential role for hypoxia

Authors: Vasiliy V. Polosukhin, William E. Lawson, Aaron P. Milstone, Svetlana M. Egunova, Andrey G. Kulipanov, Sergey G. Tchuvakin, Pierre P. Massion, Timothy S. Blackwell

Published in: Virchows Archiv | Issue 4/2007

Login to get access

Abstract

In airway remodeling that occurs in association with chronic obstructive pulmonary disease (COPD), the relationship between the subepithelium and structural changes of the bronchial epithelium is not well defined. To investigate whether the subepithelium and epithelium undergo remodeling as an integrated unit, we performed morphological examination of 55 bronchial biopsy specimens obtained from explanted or resected lungs from tobacco smokers with COPD. Our results indicate that reticular basement membrane (RBM) thickness is increased and the subepithelial microvascular bed is reduced in association with progression from the normal epithelium to squamous metaplasia. Subsequent bronchial epithelial transformation to dysplasia is characterized by differential subepithelial remodeling with normalization of RBM thickness and subepithelial blood vessel density. Because fibrous remodeling of the subepithelium could limit delivery of nutrients and oxygen to the epithelium, we assessed expression of hypoxia-inducible factor-1α (HIF-1α) and carbonic anhydrase IX (CA IX) as markers of cellular hypoxia. The number of HIF-1α-positive epithelial cells increased with progression of epithelial structural changes, RBM thickness, and reduction in blood vessels in the subepithelium. These findings suggest that the HIF-1α pathway is activated in response to subepithelial remodeling and contributes to progressive premalignant epithelial lesions in the airways of tobacco smokers with chronic airway inflammation.
Literature
1.
Arsham AM, Plas DR, Thompson CB, Simon MC (2002) Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1 alpha nor sufficient for HIF-1-dependent target gene transcription. J Biol Chem 277:15162–15170PubMedCrossRef
2.
Bardos JI, Ashcroft M (2005) Negative and positive regulation of HIF-1: a complex network. Biochim Biophys Acta 1755:107–120PubMed
3.
Bindra RS, Glazer PM (2005) Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis. Mutat Res 569:75–85PubMed
4.
Breuer RH, Pasic A, Smit EF, van Vliet E, Vonk NA, Risse EJ, Postmus PE, Sutedja TG (2005) The natural course of preneoplastic lesions in bronchial epithelium. Clin Cancer Res 11:537–543PubMed
5.
Breuer RH, Postmus PE, Smit EF (2005) Molecular pathology of non-small-cell lung cancer. Respiration 72:313–330PubMedCrossRef
6.
7.
8.
de Boer WI, Hau CM, van Schadewijk A, Stolk J, van Krieken JH, Hiemstra PS (2006) Expression of epidermal growth factors and their receptors in the bronchial epithelium of subjects with chronic obstructive pulmonary disease. Am J Clin Pathol 125:184–192PubMedCrossRef
9.
Dery MA, Michaud MD, Richard DE (2005) Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol 37:535–540PubMedCrossRef
10.
Ferrara N (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25:581–611PubMedCrossRef
11.
Forgacs E, Zochbauer-Muller S, Olah E, Minna JD (2001) Molecular genetic abnormalities in the pathogenesis of human lung cancer. Pathol Oncol Res 7:6–13PubMedCrossRef
12.
Galateau-Salle FB, Luna RE, Horiba K, Sheppard MN, Hayashi T, Fleming MV, Colby TV, Bennett W, Harris CC, Stetler-Stevenson WG, Liotta L, Ferrans VJ, Travis WD (2000) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesions. Hum Pathol 31:296–305PubMedCrossRef
13.
14.
Greijer AE, van der GP, Kemming D, Shvarts A, Semenza GL, Meijer GA, van de Wiel MA, Belien JA, van Diest PJ, van der WE (2005) Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol 206:291–304PubMedCrossRef
15.
Haddad JJ, Harb HL (2005) Cytokines and the regulation of hypoxia-inducible factor (HIF)-1alpha. Int Immunopharmacol 5:461–483PubMedCrossRef
16.
Haugland HK, Vukovic V, Pintilie M, Fyles AW, Milosevic M, Hill RP, Hedley DW (2002) Expression of hypoxia-inducible factor-1alpha in cervical carcinomas: correlation with tumor oxygenation. Int J Radiat Oncol Biol Phys 53:854–861PubMedCrossRef
17.
Hirsch FR, Merrick DT, Franklin WA (2002) Role of biomarkers for early detection of lung cancer and chemoprevention. Eur Respir J 19:1151–1158PubMedCrossRef
18.
Hofseth LJ, Ying L (2006) Identifying and defusing weapons of mass inflammation in carcinogenesis. Biochim Biophys Acta 1765:74–84PubMed
19.
Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350:2645–2653PubMedCrossRef
20.
Jeanmart M, Lantuejoul S, Fievet F, Moro D, Sturm N, Brambilla C, Brambilla E (2003) Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer. Clin Cancer Res 9:2195–2203PubMed
21.
Jeffery PK (2001) Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 164:S28–S38PubMed
22.
Karin M, Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749–759PubMedCrossRef
23.
24.
Kietzmann T, Krones-Herzig A, Jungermann K (2002) Signaling cross-talk between hypoxia and glucose via hypoxia-inducible factor 1 and glucose response elements. Biochem Pharmacol 64:903–911PubMedCrossRef
25.
Kim SJ, Rabbani ZN, Dewhirst MW, Vujaskovic Z, Vollmer RT, Schreiber EG, Oosterwijk E, Kelley MJ (2005) Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer. Lung Cancer 49:325–335PubMedCrossRef
26.
Knight DA, Holgate ST (2003) The airway epithelium: structural and functional properties in health and disease. Respirology 8:432–446PubMedCrossRef
27.
Lantuejoul S, Constantin B, Drabkin H, Brambilla C, Roche J, Brambilla E (2003) Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines. J Pathol 200:336–347PubMedCrossRef
28.
Lawson WE, Polosukhin VV, Stathopoulos GT, Zoia O, Han W, Lane KB, Li B, Donnelly EF, Holburn GE, Lewis KG, Collins RD, Hull WM, Glasser SW, Whitsett JA, Blackwell TS (2005) Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratracheal bleomycin. Am J Pathol 167:1267–1277PubMed
29.
Lawson WE, Polosukhin VV, Zoia O, Stathopoulos GT, Han W, Plieth D, Loyd JE, Neilson EG, Blackwell TS (2005) Characterization of fibroblast-specific protein 1 in pulmonary fibrosis. Am J Respir Crit Care Med 171:899–907PubMedCrossRef
30.
Lu H, Ouyang W, Huang C (2006) Inflammation, a key event in cancer development. Mol Cancer Res 4:221–233PubMedCrossRef
31.
Massion PP, Carbone DP (2003) The molecular basis of lung cancer: molecular abnormalities and therapeutic implications. Respir Res 4:12PubMedCrossRef
32.
McColl BK, Stacker SA, Achen MG (2004) Molecular regulation of the VEGF family—inducers of angiogenesis and lymphangiogenesis. APMIS Acta Pathol Microbial Immunol Scand 112:463–480
33.
Merrick DT, Haney J, Petrunich S, Sugita M, Miller YE, Keith RL, Kennedy TC, Franklin WA (2005) Overexpression of vascular endothelial growth factor and its receptors in bronchial dypslasia demonstrated by quantitative RT-PCR analysis. Lung Cancer 48:31–45PubMedCrossRef
34.
Moro-Sibilot D, Fievet F, Jeanmart M, Lantuejoul S, Arbib F, Laverribre MH, Brambilla E, Brambilla C (2004) Clinical prognostic indicators of high-grade pre-invasive bronchial lesions. Eur Respir J 24:24–29PubMedCrossRef
35.
Munoz-Najar UM, Neurath KM, Vumbaca F, Claffey KP (2006) Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation. Oncogene 25:2379–2392PubMedCrossRef
36.
Papi A, Casoni G, Caramori G, Guzzinati I, Boschetto P, Ravenna F, Calia N, Petruzzelli S, Corbetta L, Cavallesco G, Forini E, Saetta M, Ciaccia A, Fabbri LM (2004) COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma. Thorax 59:679–681PubMedCrossRef
37.
Peters EJ, Morice R, Benner SE, Lippman S, Lukeman J, Lee JS, Ro JY, Hong WK (1993) Squamous metaplasia of the bronchial mucosa and its relationship to smoking. Chest 103:1429–1432PubMed
38.
Polosukhin VV (2001) Ultrastructure of the bronchial epithelium in chronic inflammation. Ultrastruct Pathol 25:119–128PubMedCrossRef
39.
Postma DS, Timens W (2006) Remodeling in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 3:434–439PubMedCrossRef
40.
Rollins BJ (2006) Inflammatory chemokines in cancer growth and progression. Eur J Cancer 42:760–767PubMedCrossRef
41.
Sacco O, Silvestri M, Sabatini F, Sale R, Defilippi AC, Rossi GA (2004) Epithelial cells and fibroblasts: structural repair and remodelling in the airways. Paediatr Respir Rev 5(Suppl A):S35–S40PubMed
42.
Schwartz AG, Ruckdeschel JC (2006) Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173:16–22PubMedCrossRef
43.
Semenza GL (2004) Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda) 19:176–182
44.
Swinson DE, Jones JL, Cox G, Richardson D, Harris AL, O’Byrne KJ (2004) Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways. Int J Cancer 111:43–50PubMedCrossRef
45.
Swinson DE, Jones JL, Richardson D, Wykoff C, Turley H, Pastorek J, Taub N, Harris AL, O’Byrne KJ (2003) Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. J Clin Oncol 21:473–482PubMedCrossRef
46.
Swinson DE, O’Byrne KJ (2006) Interactions between hypoxia and epidermal growth factor receptor in non-small-cell lung cancer. Clin Lung Cancer 7:250–256PubMedCrossRef
47.
Vordermark D, Kaffer A, Riedl S, Katzer A, Flentje M (2005) Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells. Int J Radiat Oncol Biol Phys 61:1197–1207PubMedCrossRef
48.
Williams KJ, Parker CA, Stratford IJ (2005) Exogenous and endogenous markers of tumour oxygenation status: definitive markers of tumour hypoxia? Adv Exp Med Biol 566:285–294PubMedCrossRef
49.
Wouters EF (2005) Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2:26–33PubMedCrossRef
50.
Zhou J, Brune B (2006) Cytokines and hormones in the regulation of hypoxia inducible factor-1alpha (HIF-1alpha). Cardiovasc Hematol Agents Med Chem 4:189–197PubMed
Metadata
Title
Association of progressive structural changes in the bronchial epithelium with subepithelial fibrous remodeling: A potential role for hypoxia
Authors
Vasiliy V. Polosukhin
William E. Lawson
Aaron P. Milstone
Svetlana M. Egunova
Andrey G. Kulipanov
Sergey G. Tchuvakin
Pierre P. Massion
Timothy S. Blackwell
Publication date
01-10-2007
Publisher
Springer-Verlag
Published in
Virchows Archiv / Issue 4/2007
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-007-0469-5

Other articles of this Issue 4/2007

Virchows Archiv 4/2007 Go to the issue

Erratum

The spectrum of persistence of testicular blastema and ectopic testicular parenchyma: a possible result of focal delay in gonadal development

Case Report

Primary epithelioid sarcoma of the oesophagus

Review and Perspective

Mutation analysis of gastrointestinal stromal tumors: increasing significance for risk assessment and effective targeted therapy

Original Article

Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancer

Original Article

Changes in the profile of simple mucin-type O-glycans and polypeptide GalNAc-transferases in human testis and testicular neoplasms are associated with germ cell maturation and tumour differentiation

Case Report

Mucinous carcinoma of thyroid gland. Report of a primary and a metastatic mucinous tumour from ovarian adenocarcinoma with immunohistochemical study and review of literature